Skip to main content

Table 4 Lp-PLA2 activity and LDL by APOE ε4 status

From: Plasma lipoprotein-associated phospholipase A2 activity in Alzheimer's disease, amnestic mild cognitive impairment, and cognitively healthy elderly subjects: a cross-sectional study

  

APOE E4+

APOE E4-

Normal control (n = 66)

Lp-PLA2, nmol/min/ml (mean, SD)

206.5 (27.0)

194.7 (42.8)

 

LDL, mmol/L (mean, SD)

3.1 (1.3)

3.0 (1.1)

aMCI (n = 59)

Lp-PLA2, nmol/min/ml (mean, SD)

215.6 (42.1)

195.0 (42.9)

 

LDL, mmol/L (mean, SD)

3.1 (0.8)

2.8 (0.8)

AD (n = 78)

Lp-PLA2, nmol/min/ml (mean, SD)

207.9 (41.2)*

181.6 (26.0)*

 

LDL, mmol/L (mean, SD)

3.1 (1.2)*

2.6 (0.6)*

  1. *P < 0.05 (t-test; values in bold).
Back to article page

Alzheimer's Research & Therapy

ISSN: 1758-9193